Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-15 to 2023-02-16
Current total value of award: $359.72
Description: 4560136210!LORAZEPAM 2 MG/ML VIALML